76 related articles for article (PubMed ID: 7887076)
1. Desmoplastic small round cell tumor presenting in pleural fluid and accompanied by desmin-positive mesothelial cells.
Choi JK; van Hoeven K; Brooks JJ; Gupta PK
Acta Cytol; 1995; 39(2):377-8. PubMed ID: 7887076
[No Abstract] [Full Text] [Related]
2. Immunophenotype of desmoplastic small round cell tumors as detected in cases with EWS-WT1 gene fusion product.
Zhang PJ; Goldblum JR; Pawel BR; Fisher C; Pasha TL; Barr FG
Mod Pathol; 2003 Mar; 16(3):229-35. PubMed ID: 12640103
[TBL] [Abstract][Full Text] [Related]
3. Effusion cytology of desmoplastic small round cell tumor of the pleura. A case report.
Bian Y; Jordan AG; Rupp M; Cohn H; McLaughlin CJ; Miettinen M
Acta Cytol; 1993; 37(1):77-82. PubMed ID: 7679537
[TBL] [Abstract][Full Text] [Related]
4. Distinguishing benign from malignant mesothelial cells in effusions by Glut-1, EMA, and Desmin expression: an evidence-based approach.
Kuperman M; Florence RR; Pantanowitz L; Visintainer PF; Cibas ES; Otis CN
Diagn Cytopathol; 2013 Feb; 41(2):131-40. PubMed ID: 23002041
[TBL] [Abstract][Full Text] [Related]
5. Cytopathologic differential diagnosis of malignant mesothelioma, adenocarcinoma and reactive mesothelial cells: A logistic regression analysis.
Cakir E; Demirag F; Aydin M; Unsal E
Diagn Cytopathol; 2009 Jan; 37(1):4-10. PubMed ID: 18973123
[TBL] [Abstract][Full Text] [Related]
6. Malignant mesothelioma: immunohistochemistry and DNA ploidy analysis as methods to differentiate mesothelioma from benign reactive mesothelial cell proliferation and adenocarcinoma in pleural and peritoneal effusions.
Friedman MT; Gentile P; Tarectecan A; Fuchs A
Arch Pathol Lab Med; 1996 Oct; 120(10):959-66. PubMed ID: 12046609
[TBL] [Abstract][Full Text] [Related]
7. D2-40 is not a specific marker for cells of mesothelial origin in serous effusions.
Bassarova AV; Nesland JM; Davidson B
Am J Surg Pathol; 2006 Jul; 30(7):878-82. PubMed ID: 16819331
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of the expression of tumor-associated antigen, RCAS1, and its soluble protein in pleural fluid in malignant mesothelioma.
Hiraki A; Aoe K; Murakami T; Nakamura Y; Yamazaki K; Sueoka N; Taguchi K; Kamei T; Maeda T; Takeyama H; Kishimoto T; Nishimura M; Sugi K
Oncol Rep; 2005 Aug; 14(2):357-62. PubMed ID: 16012715
[TBL] [Abstract][Full Text] [Related]
9. Serous effusions in malignant lymphomas: a review.
Das DK
Diagn Cytopathol; 2006 May; 34(5):335-47. PubMed ID: 16604559
[TBL] [Abstract][Full Text] [Related]
10. Desmoplastic small round cell tumor with sphere-like clusters mimicking adenocarcinoma.
Hattori Y; Yoshida A; Sasaki N; Shibuki Y; Tamura K; Tsuta K
Diagn Cytopathol; 2015 Mar; 43(3):214-7. PubMed ID: 24819999
[TBL] [Abstract][Full Text] [Related]
11. Use of a panel of markers in the differential diagnosis of adenocarcinoma and reactive mesothelial cells in fluid cytology.
Ko EC; Jhala NC; Shultz JJ; Chhieng DC
Am J Clin Pathol; 2001 Nov; 116(5):709-15. PubMed ID: 11710688
[TBL] [Abstract][Full Text] [Related]
12. Intra-abdominal desmoplastic small round-cell tumor: expansion of the pathologic profile.
Dorsey BV; Benjamin LE; Rauscher F; Klencke B; Venook AP; Warren RS; Weidner N
Mod Pathol; 1996 Jun; 9(6):703-9. PubMed ID: 8782211
[TBL] [Abstract][Full Text] [Related]
13. Benign metastasizing mesothelial cells in an axillary lymph node secondary to a chest wall fibromatosis.
Moonim MT; Herbert A; Lucas SB
Histopathology; 2006 Feb; 48(3):303-5. PubMed ID: 16430477
[No Abstract] [Full Text] [Related]
14. Diagnostic utility of D2-40 and podoplanin in effusion cell blocks.
Bhalla R; Siddiqui MT; Mandich D; Cartun RW; Fiel-Gan MD; Nassar A; Mandavilli SR
Diagn Cytopathol; 2007 Jun; 35(6):342-7. PubMed ID: 17497664
[TBL] [Abstract][Full Text] [Related]
15. Unusual cytologic manifestation of small-cell lung cancer in associated pleural effusion.
Smith R; Nguyen GK
Diagn Cytopathol; 2004 Apr; 30(4):266-7. PubMed ID: 15048963
[No Abstract] [Full Text] [Related]
16. The value of ThinPrep and cytospin preparation in pleural effusion cytological diagnosis of mesothelioma and adenocarcinoma.
Ylagan LR; Zhai J
Diagn Cytopathol; 2005 Mar; 32(3):137-44. PubMed ID: 15690333
[TBL] [Abstract][Full Text] [Related]
17. Differentiation of mesothelioma from adenocarcinoma in serous effusions: the role of hyaluronic acid and CD44 localization.
Afify AM; Stern R; Michael CW
Diagn Cytopathol; 2005 Mar; 32(3):145-50. PubMed ID: 15690337
[TBL] [Abstract][Full Text] [Related]
18. The use of immunohistochemistry to distinguish reactive mesothelial cells from malignant mesothelioma in cytologic effusions.
Geyer SJ
Cancer Cytopathol; 2010 Aug; 118(4):225; author reply 225. PubMed ID: 20731007
[No Abstract] [Full Text] [Related]
19. Benign metastasizing mesothelial cells: a potential pitfall in mediastinal lymph nodes.
Moonim MT; Ng WW; Routledge T
J Clin Oncol; 2011 Jun; 29(18):e546-8. PubMed ID: 21482984
[No Abstract] [Full Text] [Related]
20. The cell adhesion molecule, E-cadherin, distinguishes mesothelial cells from carcinoma cells in fluids.
Schofield K; D'Aquila T; Rimm DL
Cancer; 1997 Oct; 81(5):293-8. PubMed ID: 9349517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
